AgeX Therapeutics Company
Biotechnology relating to cellular immortality and regenerative biology
Technology:
Geroscience
Industry:
BioEngineering
Headquarters:
California, United States
Founded Date:
2017
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
7
Total Funding:
63786000
Estimated Revenue:
Less than $1M
Last Funding Date:
2018
Last Funding Type:
Private Equity
Register and Claim Ownership